PNC Financial Services Group
FDMT icon

PNC Financial Services Group’s 4D Molecular Therapeutics FDMT Stock Holding History

PNC Financial Services Group’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.6K Sell
1,462
-5,713
-80% -$49.7K ﹤0.01% 3847
2025
Q4 		$53.8K Sell
7,175
-131
-2% -$1.33K ﹤0.01% 3171
2025
Q3 		$63.5K Sell
7,306
-1,854
-20% -$11.1K ﹤0.01% 3065
2025
Q2 		$34K Buy
9,160
+1,257
+16% +$4.42K ﹤0.01% 3326
2025
Q1 		$25.5K Sell
7,903
-1,221
-13% -$5.75K ﹤0.01% 3430
2024
Q4 		$50.8K Buy
9,124
+3,630
+66% +$28.5K ﹤0.01% 3097
2024
Q3 		$59.4K Buy
5,494
+1,134
+26% +$18.8K ﹤0.01% 2989
2024
Q2 		$91.5K Buy
4,360
+4,332
+15,471% +$109K ﹤0.01% 2687
2024
Q1 		$892 Sell
28
-4
-13% -$102 ﹤0.01% 4386
2023
Q4 		$648 Buy
+32
New +$421 ﹤0.01% 4372

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return